Results 11 to 20 of about 298,741 (199)

Human Papillomavirus Vaccines: An Updated Review [PDF]

Vaccines, 2020
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated
Liqin Cheng, Yan Wang, Juan Du
doaj   +3 more sources

Global challenges of implementing human papillomavirus vaccines [PDF]

International Journal for Equity in Health, 2011
Human Papillomavirus vaccines are widely hailed as a sweeping pharmaceutical innovation for the universal benefit of all women. The implementation of the vaccines, however, is far from universal or equitable.
Mishra Amrita, Graham Janice E
doaj   +6 more sources

A Pocket Manual for Human Papillomavirus Vaccines [PDF]

Vaccines
Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and is responsible for the majority of cervical, anal, and vaginal cancers. The first prophylactic HPV vaccine was introduced in the United States in 2006.
Natalie A. Voss, J. Brooks Jackson, Mary B. Rysavy   +2 more
doaj   +2 more sources

Human papillomavirus vaccines: A great leap forward [PDF]

Case Reports in Women's Health, 2022
Marie Louise Frevert, Florin-Andrei Taran   +1 more
doaj   +2 more sources

Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study. [PDF]

Vaccines (Basel), 2023
Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL® hereafter referred to as ...
Guimarães EL, Chissaque A, Pecenka C, Debellut F, Schuind A, Vaz B, Banze A, Rangeiro R, Mariano A, Lorenzoni C, Carrilho C, Martins MDRO, de Deus N, Clark A.   +13 more
europepmc   +2 more sources

Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan

Women's Health, 2023
Background: Although recommended for all member states of World Health Organization, there is no national human papillomavirus vaccination program in Kazakhstan.
Aisha Babi, Torgyn Issa, Alpamys Issanov, Sholpan Akhanova, Natalya Udalova, Svetlana Koktova, Askhat Balykov, Zhanna Sattarkyzy, Balkenzhe Imankulova, Nazira Kamzayeva, Wassim Y. Almawi, Gulzhanat Aimagambetova   +11 more
doaj   +1 more source

Prices of paediatric vaccines in European vaccination programmes

Vaccine: X, 2023
Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe.
Heini Salo, Milda Sakalauskaitè, Daniel Lévy-Bruhl, Ann Lindstrand, Palle Valentiner-Branth, Ole Wichmann, Taneli Puumalainen   +6 more
doaj   +1 more source

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.

PLoS Pathogens, 2020
High-risk human papillomaviruses (HPVs) cause 5% of human cancers. Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals ...
Wei Wang, Aayushi Uberoi, Megan Spurgeon, Ellery Gronski, Vladimir Majerciak, Alexei Lobanov, Mitchell Hayes, Amanda Loke, Zhi-Ming Zheng, Paul F Lambert   +9 more
doaj   +1 more source

Prophylactic HPV vaccines [PDF]

Archive of Oncology, 2009
Human papillomavirus (HPV) is one of the most common sexually transmitted diseases worldwide. Cervical and other anogenital cancers, cervical and anal intraepithelial neoplasia, genital warts, and recurrent respiratory papillomatosis are HPV associated ...
Mandić Aljoša
doaj   +1 more source

Novel Antigenic Targets of HPV Therapeutic Vaccines

Vaccines, 2021
Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical ...
Ditte Rahbæk Boilesen, Karen Nørgaard Nielsen, Peter Johannes Holst   +2 more
doaj   +1 more source